USP37
Basic information
Region (hg38): 2:218450251-218568351
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the USP37 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 30 | 34 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 30 | 4 | 3 |
Variants in USP37
This is a list of pathogenic ClinVar variants found in the USP37 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-218454943-C-T | Benign (Jul 26, 2018) | |||
2-218454956-C-T | not specified | Uncertain significance (Sep 20, 2023) | ||
2-218454995-C-T | not specified | Uncertain significance (Apr 26, 2023) | ||
2-218455610-C-T | not specified | Uncertain significance (Oct 26, 2021) | ||
2-218455710-T-C | not specified | Uncertain significance (Feb 27, 2023) | ||
2-218459787-T-C | Likely benign (Sep 01, 2023) | |||
2-218463357-C-T | not specified | Uncertain significance (Dec 08, 2023) | ||
2-218466107-G-C | not specified | Uncertain significance (Dec 21, 2023) | ||
2-218466124-G-A | Benign (Aug 14, 2017) | |||
2-218474666-T-C | not specified | Likely benign (Oct 13, 2023) | ||
2-218474821-A-C | not specified | Uncertain significance (Jun 30, 2022) | ||
2-218476866-C-T | not specified | Uncertain significance (Mar 18, 2024) | ||
2-218479692-T-C | not specified | Uncertain significance (Sep 16, 2021) | ||
2-218482092-C-A | not specified | Uncertain significance (Jan 10, 2023) | ||
2-218488351-G-T | not specified | Uncertain significance (Jan 31, 2022) | ||
2-218488414-C-T | Uncertain significance (Sep 01, 2023) | |||
2-218495785-C-T | not specified | Uncertain significance (Jun 07, 2024) | ||
2-218495803-T-C | not specified | Uncertain significance (May 27, 2022) | ||
2-218495852-T-G | not specified | Uncertain significance (May 30, 2024) | ||
2-218495916-T-C | not specified | Uncertain significance (Dec 05, 2022) | ||
2-218495939-T-C | Likely benign (Dec 01, 2022) | |||
2-218497744-T-C | not specified | Uncertain significance (Oct 26, 2021) | ||
2-218510015-A-C | not specified | Uncertain significance (Mar 28, 2023) | ||
2-218510021-G-C | Benign (Aug 14, 2017) | |||
2-218510082-G-T | not specified | Uncertain significance (May 02, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
USP37 | protein_coding | protein_coding | ENST00000258399 | 23 | 118111 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.00000654 | 125730 | 0 | 16 | 125746 | 0.0000636 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.46 | 345 | 500 | 0.690 | 0.0000248 | 6439 |
Missense in Polyphen | 64 | 149.68 | 0.42759 | 2061 | ||
Synonymous | 0.891 | 160 | 175 | 0.914 | 0.00000879 | 1783 |
Loss of Function | 6.28 | 5 | 55.5 | 0.0901 | 0.00000291 | 688 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000936 | 0.0000936 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000890 | 0.0000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000993 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Deubiquitinase that antagonizes the anaphase-promoting complex (APC/C) during G1/S transition by mediating deubiquitination of cyclin-A (CCNA1 and CCNA2), thereby promoting S phase entry. Specifically mediates deubiquitination of 'Lys-11'- linked polyubiquitin chains, a specific ubiquitin-linkage type mediated by the APC/C complex. Also mediates deubiquitination of 'Lys-48'-linked polyubiquitin chains in vitro. Phosphorylation at Ser-628 during G1/S phase maximizes the deubiquitinase activity, leading to prevent degradation of cyclin-A (CCNA1 and CCNA2) (PubMed:21596315). Plays an important role in the regulation of DNA replication by stabilizing the licensing factor CDT1 (PubMed:27296872). {ECO:0000269|PubMed:21596315, ECO:0000269|PubMed:27296872}.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Ub-specific processing proteases;Deubiquitination
(Consensus)
Recessive Scores
- pRec
- 0.0969
Intolerance Scores
- loftool
- 0.460
- rvis_EVS
- 0.49
- rvis_percentile_EVS
- 79.52
Haploinsufficiency Scores
- pHI
- 0.310
- hipred
- Y
- hipred_score
- 0.526
- ghis
- 0.540
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.841
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Usp37
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- G1/S transition of mitotic cell cycle;regulation of DNA replication;ubiquitin-dependent protein catabolic process;protein deubiquitination;protein K11-linked deubiquitination;cell division;protein K48-linked deubiquitination
- Cellular component
- nucleus;nucleoplasm
- Molecular function
- cysteine-type endopeptidase activity;thiol-dependent ubiquitin-specific protease activity;protein binding;protein kinase binding;thiol-dependent ubiquitinyl hydrolase activity